Save time and get answers to complex questions with AI chat
Drugpatentwatch skyrizi biologic patent analysis?Zemdri plazomicin nce gain exclusivity 2028 patent 2031?Patent term adjustment semaglutida?Pramlintide approval date?What is dabrafenib mesylate msn patent issue?
See the DrugPatentWatch profile for armodafinil
Armodafinil is a prescription wakefulness‑promoting medicine (the R-enantiomer of modafinil). Approved uses (in adults): - Narcolepsy - Obstructive sleep apnea/hypopnea syndrome (OSAHS) - Shift work sleep disorder (SWSD) What it does: helps people stay awake and alert during the day and may improve daytime functioning. How it’s taken: usually once daily in the morning for narcolepsy/OSAHS, or about 1 hour before a night shift for SWSD. Doses commonly are 150 mg or 250 mg, but the exact dose is decided by a clinician. Notes: - Not approved for children. - Some people may experience side effects (e.g., headache, nausea) and there are rare risks like severe skin reactions. - It can interact with other medicines and may affect hormonal contraceptives; discuss all meds with your doctor. If you’re considering armodafinil, talk to your healthcare provider to see if it’s appropriate for you. This is general information and not medical advice.
Other Questions About Armodafinil :